J Lab Med Qual Assur.  2015 Mar;37(1):12-22. 10.15263/jlmqa.2015.37.1.12.

Annual Report on the External Quality Assessment Scheme for Therapeutic Drug Monitoring and Testing for Drugs of Abuse in Korea (2014)

• Ko DH
• Jeong TD
• Gu GG
• Chun S
• Kim JH
• Therapeutic Drug Monitoring Subcommittee, The Korean Association of Quality Assurance for Clinical Laboratories

• KMID: 1789358
• DOI: http://doi.org/10.15263/jlmqa.2015.37.1.12

Abstract

As the Therapeutic Drug Monitoring Subcommittee (TDMS) of the Korean Association of Quality Assurance for Clinical Laboratories (KAQACL), we organised two trials as an external quality assessment of therapeutic drug monitoring (TDM) and testing for drugs of abuse (DOA) in 2014. In each trial, low and high level control materials for TDM testing, and positive and negative control materials for DOA testing, were requested from institutions. The number of participating laboratories was 107 for the first trial and 106 for the second. The average number of drug items provided was 5.7 per institution. The most commonly tested substances were, in descending order, valproic acid, digoxin, tacrolimus, phenytoin, and vancomycin. The mean inter-laboratory coefficients of variation for low- and high-level TDM control materials were 8.5% and 7.2%, respectively. The most widely used TDM analysers were the Architect i System (Abbott Diagnostics, USA), followed by the Cobas Integra (Roche Diagnostics, Switzerland) and the Cobas c501 analyser (Roche Diagnostics). The number of participating laboratories for DOA testing was 23% higher that than in 2013. In 96.9% of cases, our analysis confirmed the suitability of the tests at participating DOA laboratories in both trials. In the external quality assessment of TDM by the TDMS of KAQACL in 2014, the overall performance of TDM testing was found to be similar to that observed in the previous years, and inter-laboratory precision was higher than that in 2013. Continuous quality improvement of TDM testing by participation in a proficiency-testing program is necessary.

Keyword

Quality assurance; Laboratory proficiency testing; Drug monitoring

MeSH Terms

Digoxin
Drug Monitoring*
Korea
Laboratory Proficiency Testing
Phenytoin
Quality Improvement
Street Drugs*
Tacrolimus
Valproic Acid
Vancomycin
Digoxin
Phenytoin
Street Drugs
Tacrolimus
Valproic Acid
Vancomycin